Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

MGTX

MeiraGTx Holdings plc

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 1735438Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$81.0M
Net Income FY2025
$(114.0M)
EPS (Basic, as reported)
$-1.42
Net Margin FY2025
-140.3%
ROE FY2025
1971.4%
Total Equity
$(6.0M)
Shares Out
96M
Business description

MeiraGTx Holdings plc — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2017–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 13 → 81 +35.7% CAGR
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue——13163816143381
Research & development(22)(34)(25)(34)(67)(86)(104)(119)(130)
Selling & marketing———————(24)(5)
General & administrative(9)(44)(47)(44)(44)(47)(47)(54)(53)
Total operating expenses(32)(78)(72)(78)(111)(132)(151)(197)(187)
Operating income(32)(78)(58)(63)(73)(116)(137)(164)(106)
Interest expense00000(5)(13)(13)(12)
Interest & investment income000101242
Pre-tax income(31)(83)(55)(58)(80)(130)(84)(148)(114)
Income tax expense00000—000
Net income(31)(83)(55)(58)(80)(130)(84)(148)(114)
EPS — basic———($1.54)($1.80)($2.87)($1.49)($2.12)($1.42)
EPS — diluted———($1.54)($1.80)($2.87)($1.49)($2.12)($1.42)
Shares outstanding — basic (M)———384445567080
Shares outstanding — diluted (M)———384445567080

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.